BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8083811)

  • 1. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug.
    Sakane T; Akizuki M; Yamashita S; Sezaki H; Nadai T
    J Pharm Pharmacol; 1994 May; 46(5):378-9. PubMed ID: 8083811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug.
    Sakane T; Akizuki M; Yamashita S; Nadai T; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2456-8. PubMed ID: 1804561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs.
    Sakane T; Akizuki M; Taki Y; Yamashita S; Sezaki H; Nadai T
    J Pharm Pharmacol; 1995 May; 47(5):379-81. PubMed ID: 7494186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
    Sakane T; Akizuki M; Yoshida M; Yamashita S; Nadai T; Hashida M; Sezaki H
    J Pharm Pharmacol; 1991 Jun; 43(6):449-51. PubMed ID: 1681064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity.
    van den Berg MP; Romeijn SG; Verhoef JC; Merkus FW
    J Neurosci Methods; 2002 Apr; 116(1):99-107. PubMed ID: 12007987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transnasal delivery of 5-fluorouracil to the brain in the rat.
    Sakane T; Yamashita S; Yata N; Sezaki H
    J Drug Target; 1999; 7(3):233-40. PubMed ID: 10680979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats.
    Dahlin M; Björk E
    Int J Pharm; 2000 Feb; 195(1-2):197-205. PubMed ID: 10675697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
    Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
    Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of antihistamines into the CSF following intranasal delivery.
    Chou KJ; Donovan MD
    Biopharm Drug Dispos; 1997 May; 18(4):335-46. PubMed ID: 9158881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct transport of 2',3'-didehydro-3'-deoxythymidine (D4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in rats.
    Yajima T; Juni K; Saneyoshi M; Hasegawa T; Kawaguchi T
    Biol Pharm Bull; 1998 Mar; 21(3):272-7. PubMed ID: 9556159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid).
    Shingaki T; Hidalgo IJ; Furubayashi T; Katsumi H; Sakane T; Yamamoto A; Yamashita S
    Int J Pharm; 2009 Jul; 377(1-2):85-91. PubMed ID: 19446619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug disappearance from nasal cavity by the deposit method.
    Aikawa K; Uda H; Tanaka S; Shimamura H; Tsuchiya S
    Drug Des Discov; 1998 Oct; 15(4):233-8. PubMed ID: 10546068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans.
    Van den Berg MP; Merkus P; Romeijn SG; Verhoef JC; Merkus FW
    J Drug Target; 2003 Jul; 11(6):325-31. PubMed ID: 14668053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.
    Wang X; He H; Leng W; Tang X
    Int J Pharm; 2006 Jul; 317(1):40-6. PubMed ID: 16631329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of formulation viscosity on drug absorption following nasal application in rats.
    Furubayashi T; Inoue D; Kamaguchi A; Higashi Y; Sakane T
    Drug Metab Pharmacokinet; 2007 Jun; 22(3):206-11. PubMed ID: 17603222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.
    van den Berg MP; Merkus P; Romeijn SG; Verhoef JC; Merkus FW
    Pharm Res; 2004 May; 21(5):799-802. PubMed ID: 15180337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.
    Chow HS; Chen Z; Matsuura GT
    J Pharm Sci; 1999 Aug; 88(8):754-8. PubMed ID: 10430537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats.
    Seki T; Sato N; Hasegawa T; Kawaguchi T; Juni K
    Biol Pharm Bull; 1994 Aug; 17(8):1135-7. PubMed ID: 7820125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of brain-targeting for the nasal delivery of ergoloid mesylate by the microdialysis method in rats.
    Chen J; Wang X; Wang J; Liu G; Tang X
    Eur J Pharm Biopharm; 2008 Mar; 68(3):694-700. PubMed ID: 17945473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.
    Charlton ST; Davis SS; Illum L
    J Drug Target; 2007 Jun; 15(5):370-7. PubMed ID: 17541846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.